---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-028041"
form_type: "8-K"
ticker: "MAIA"
cik: "0001878313"
company_name: "MAIA Biotechnology, Inc."
filed_at: "2025-12-17T23:59:59+00:00"
generated_at: "2026-05-16T12:57:02.713717+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# MAIA Biotechnology announces $1.51M private placement of common stock and warrants

## Summary
- Gross proceeds ~$1.51M from 1,233,488 shares at $1.224 each, with warrants exercisable at $1.36.
- Warrants exercisable six months after issuance, three-year term, priced at NYSE American minimum price.
- Directors subscribe for 179,737 shares (~$220k); Louie Ngar Yee, Stan Smith, Steven Chaouki.
- Net proceeds to fund Step 1 of Part C of Phase II THIO-101 trial and working capital.
- Expected close Dec 18, 2025; securities unregistered, offered under Section 4(a)(2)/Reg D.

## SEC filing metadata
- accession: 0001493152-25-028041
- form_type: 8-K
- ticker: MAIA
- cik: 0001878313
- company_name: MAIA Biotechnology, Inc.
- filed_at: 2025-12-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1878313/000149315225028041/0001493152-25-028041-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1878313/000149315225028041/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-028041
- JSON: https://secwatch.observer/filing/0001493152-25-028041.json
- Plain text: https://secwatch.observer/filing/0001493152-25-028041.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.